Drug Profile
Research programme: neurokinin-2 receptor antagonists - Menarini
Alternative Names: Tachykinin NK2 receptor antagonists - MenariniLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Menarini
- Class Heterocyclic compounds
- Mechanism of Action Neurokinin 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in Italy
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Italy
- 18 Mar 2008 Preclinical trials in Pain in Italy (unspecified route)